{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T11:34:53Z","timestamp":1774611293000,"version":"3.50.1"},"reference-count":28,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Rationale:<\/jats:title>\n            <jats:p>Brain metastases are extremely rare for patients with pancreatic adenocarcinoma due to the poor prognoses. In the present study, we reported 2 cases of pancreatic adenocarcinoma with brain metastases.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Patient concerns:<\/jats:title>\n            <jats:p>The 1st patient was diagnosed asymptomatic brain metastasis by a follow-up brain magnetic resonance imaging (MRI) due to a medical history of subarachnoid hemorrhage. The 2nd patient experienced dizziness, neck pain, and seizure. Computed tomography (CT) was used for the diagnosis of brain metastasis because he was inserted a pacemaker.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Diagnosis:<\/jats:title>\n            <jats:p>In case 1, brain MRI revealed that a solitary brain metastasis 14-mm in size was identified at the cortico-medullary junction in the left frontal lobe. In case 2, brain enhanced CT revealed multiple brain metastases with calcification at the cerebral cortex. Times to develop central nervous system metastasis were 19 months and 33 months, respectively.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Interventions:<\/jats:title>\n            <jats:p>The 1st patient was treated with 45.2 Gy \u03b3-knife irradiation for the solitary brain metastasis, and the 2nd patient was treated with supportive care due to the poor general condition.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Outcomes:<\/jats:title>\n            <jats:p>The prognoses of these 2 patients were 13 months, and 32 days from the diagnosis of brain metastasis. The 1st patient did not experience complication of a \u03b3-knife irradiation and brain metastasis was controlled until death.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Lessons:<\/jats:title>\n            <jats:p>The incidence of brain metastases from pancreatic adenocarcinoma is expected to increase due to prolonged survival from improved treatment. Therefore, increased awareness of brain involvement is necessary when neurological disorder is suspected in patients with advanced pancreatic cancer.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000014227","type":"journal-article","created":{"date-parts":[[2019,1,25]],"date-time":"2019-01-25T07:15:32Z","timestamp":1548400532000},"page":"e14227","source":"Crossref","is-referenced-by-count":18,"title":["Brain metastasis in pancreatic cancer"],"prefix":"10.1097","volume":"98","author":[{"given":"Takashi","family":"Sasaki","sequence":"first","affiliation":[{"name":"Department of Gastroenterology, Cancer Institute Hospital of Japanese Foundation of Cancer Research"},{"name":"Department of Gastroenterology, Graduate School of Medicine, The University of Tokyo"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatsuya","family":"Sato","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Graduate School of Medicine, The University of Tokyo"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yousuke","family":"Nakai","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Graduate School of Medicine, The University of Tokyo"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoki","family":"Sasahira","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Cancer Institute Hospital of Japanese Foundation of Cancer Research"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyuki","family":"Isayama","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Graduate School of Medicine, The University of Tokyo"},{"name":"Department of Gastroenterology, Graduate School of Medicine, Juntendo University, Tokyo, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuhiko","family":"Koike","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Graduate School of Medicine, The University of Tokyo"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20230914","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1056\/NEJMra1404198","article-title":"Pancreatic adenocarcinoma","volume":"371","author":"Ryan","year":"2014","journal-title":"N Engl J Med"},{"key":"R2-20230914","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21442","article-title":"Cancer statistics, 2018","volume":"68","author":"Siegel","year":"2018","journal-title":"CA Cancer J Clin"},{"key":"R3-20230914","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.3748\/wjg.v23.i10.1872","article-title":"Prognostic value of site-specific metastases in pancreatic adenocarcinoma: a surveillance epidemiology and end results database analysis","volume":"23","author":"Oweira","year":"2017","journal-title":"World J Gastroenterol"},{"key":"R4-20230914","doi-asserted-by":"crossref","first-page":"2698","DOI":"10.1002\/cncr.10541","article-title":"Incidence of brain metastases in a cohort of patients with carcinoma of the breast, colon, kidney, and lung and melanoma","volume":"94","author":"Schouten","year":"2002","journal-title":"Cancer"},{"key":"R5-20230914","doi-asserted-by":"crossref","first-page":"2865","DOI":"10.1200\/JCO.2004.12.149","article-title":"Incidence proportions of brain metastases in patients with diagnosed (1973 to 2001) in the Metropolitan Detroit Cancer Surveillance System","volume":"22","author":"Barnholtz-Sloan","year":"2004","journal-title":"J Clin Oncol"},{"key":"R7-20230914","first-page":"38","article-title":"Clinical picture and diagnosis of metastatic brain cancer with its primary source in the pancreas","author":"Demchuk","year":"1977","journal-title":"Vrach Delo"},{"key":"R8-20230914","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1023\/A:1024337020884","article-title":"Nervous system involvement by pancreatic cancer","volume":"63","author":"Park","year":"2003","journal-title":"J Neurooncol"},{"key":"R9-20230914","first-page":"584","article-title":"Carcinoma of pancreas and periampullary structures pattern of metastasis at autopsy","volume":"108","author":"Lee","year":"1984","journal-title":"Arch Pathol Lab Med"},{"key":"R10-20230914","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/S0090-3019(02)00805-4","article-title":"Brain metastases from asymptomatic adenocarcinoma of the pancreas: an autopsy case report","volume":"58","author":"Yamada","year":"2002","journal-title":"Surg Neurol"},{"key":"R11-20230914","first-page":"169","article-title":"Pancreatoblastoma metastases to the brain. Case illustration","volume":"106","author":"Szerlip","year":"2007","journal-title":"J Neurosurg"},{"key":"R12-20230914","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1186\/1477-7819-10-138","article-title":"Oncocytic-type intraductal papillary mucinous neoplasm (IPMN)-derived invasive oncocytic pancreatic carcinoma with brain metastasis\u2014a case report","volume":"10","author":"Chiang","year":"2012","journal-title":"World J Surg Oncol"},{"key":"R13-20230914","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1097\/MPA.0000000000000904","article-title":"Carcinosarcoma of the pancreas: case report with comprehensive literature review","volume":"46","author":"Ruess","year":"2017","journal-title":"Pancreas"},{"key":"R14-20230914","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.3748\/wjg.v21.i3.1020","article-title":"Rare cases of pancreatic cancer with leptomeningeal carcinomatosis","volume":"21","author":"Yoo","year":"2015","journal-title":"World J Gastroenterol"},{"key":"R15-20230914","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1097\/00006982-200112000-00019","article-title":"Intraocular metastasis of pancreatic cancer: report of two cases","volume":"21","author":"Lin","year":"2001","journal-title":"Retina"},{"key":"R16-20230914","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s12029-014-9667-y","article-title":"CNS involvement in pancreatic adenocarcinoma: a report of eight cases from the Johns Hopkins Hospital and review of literature","volume":"46","author":"Kumar","year":"2015","journal-title":"J Gastrointest Cancer"},{"key":"R18-20230914","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.3390\/ijms14012135","article-title":"Innovative therapeutic strategies in the treatment of brain metastases","volume":"14","author":"Caffo","year":"2013","journal-title":"Int J Mol Sci"},{"key":"R19-20230914","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1093\/neuonc\/now241","article-title":"Diagnosis and treatment of brain metastases from solid tumors: guidelines from the European Association of Neuro-Oncology (EANO)","volume":"19","author":"Soffietti","year":"2017","journal-title":"Neuro Oncol"},{"key":"R20-20230914","doi-asserted-by":"crossref","first-page":"i1","DOI":"10.1093\/neuonc\/now197","article-title":"Systemic therapy of brain metastases: non-small cell lung cancer, breast cancer, and melanoma","volume":"19","author":"Chamberlain","year":"2017","journal-title":"Neuro Oncol"},{"key":"R21-20230914","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1001\/jamaoncol.2016.5411","article-title":"The diminishing role of whole-brain radiation therapy in the treatment of brain metastases","volume":"3","author":"Li","year":"2017","journal-title":"JAMA Oncol"},{"key":"R22-20230914","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1056\/NEJMoa1704795","article-title":"Alectinib versus crizotinib in untreated ALK-positive non-small-cell lung cancer","volume":"377","author":"Peters","year":"2017","journal-title":"N Engl J Med"},{"key":"R23-20230914","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1200\/JCO.2013.54.0955","article-title":"Recommendations on disease management for patients with advanced human epidermal growth factor receptor 2-positive breast canceer and brain metastases: American Society of Clinical Oncology clinical practice guideline","volume":"32","author":"Ramakrishna","year":"2014","journal-title":"J Clin Oncol"},{"key":"R24-20230914","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.3390\/ijms17091468","article-title":"Melanoma brain metastasis: mechanisms, model, and medicine","volume":"17","author":"Kircher","year":"2016","journal-title":"Int J Mol Sci"},{"key":"R25-20230914","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1200\/JCO.2006.07.9525","article-title":"Erlotinib plus gemcitabine compared with gemcitabine alone in patients with advanced pancreatic cancer: a phase III trial of the National Cancer Institute of Canada Clinical Trials Group","volume":"25","author":"Moore","year":"2017","journal-title":"J Clin Oncol"},{"key":"R26-20230914","doi-asserted-by":"crossref","first-page":"2505","DOI":"10.1002\/cncr.25707","article-title":"Presentation, patterns of care, and survival in patients with brain metastases: what has changed in the last 20 years?","volume":"117","author":"Nieder","year":"2011","journal-title":"Cancer"},{"key":"R27-20230914","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1200\/EDBK_175679","article-title":"Systemic therapy for metastatic colorectal cancer: from current standards to future molecular targeted approaches","volume":"37","author":"Atreya","year":"2017","journal-title":"Am Soc Clin Oncol Educ Book"},{"key":"R28-20230914","doi-asserted-by":"crossref","first-page":"2913","DOI":"10.1158\/0008-5472.CAN-14-0155","article-title":"Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States","volume":"74","author":"Rahib","year":"2014","journal-title":"Cancer Res"},{"key":"R29-20230914","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1056\/NEJMoa1011923","article-title":"FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer","volume":"364","author":"Conroy","year":"2011","journal-title":"N Engl J Med"},{"key":"R30-20230914","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1056\/NEJMoa1304369","article-title":"Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine","volume":"369","author":"Von Hoff","year":"2013","journal-title":"N Engl J Med"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00005792-201901250-00052","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,14]],"date-time":"2023-09-14T18:28:20Z","timestamp":1694716100000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00005792-201901250-00052"}},"subtitle":["Two case reports"],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":28,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000014227","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1]]}}}